Freedom Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-19,682
Closed -$3.28M 996
2018
Q2
$3.28M Buy
19,682
+7,690
+64% +$1.23M 0.2% 80
2018
Q1
$2.02M Buy
+11,992
New +$2.01M 0.1% 169
2016
Q3
Sell
-4,887
Closed -$1.13M 966
2016
Q2
$1.13M Sell
4,887
-6,757
-58% -$1.56M 0.08% 191
2016
Q1
$3.12M Buy
11,644
+597
+5% +$171K 0.23% 40
2015
Q4
$3.45M Sell
11,047
-18,257
-62% -$5.44M 0.26% 43
2015
Q3
$179K Buy
29,304
+19,756
+207% +$6.07M 0.02% 619
2015
Q2
$2.9M Buy
9,548
+223
+2% +$66.5K 0.3% 45
2015
Q1
$2.77M Buy
9,325
+76
+0.8% +$21.7K 0.31% 41
2014
Q4
$2.38M Buy
+9,249
New +$2.31M 0.31% 49
2014
Q3
Sell
-1,242
Closed -$277K 530
2014
Q2
$277K Buy
+1,242
New +$257K 0.05% 357

Other funds holding AGN

Freedom Investment Management's AGN Position: Q3 2018 in Review

Freedom Investment Management sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 19,682 shares — an estimated $3.28M sold.

Freedom Investment Management first reported a position in AGN in Q2 2014 and held it in 10 quarters. The position peaked at $3.45M in Q4 2015. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Freedom Investment Management reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Freedom Investment Management sold 19,682 Allergan plc shares in Q3 2018, an estimated $3.28M.
  • Freedom Investment Management first reported a position in Allergan plc in Q2 2014 and held it in 10 quarters.
  • Freedom Investment Management's Allergan plc position peaked at $3.45M in Q4 2015.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Freedom Investment Management's 13F filing for Q3 2018, filed 17 Oct 2018.